NEUCA S.A. (WSE:NEU)

Market Cap	3.64B
Revenue (ttm)	13.34B
Net Income (ttm)	153.80M
Shares Out	4.50M
EPS (ttm)	33.88
PE Ratio	23.85
Forward PE	19.78
Dividend	16.00 (1.98%)
Ex-Dividend Date	Jul 15, 2025

Volume	3,061
Average Volume	1,601
Open	809.00
Previous Close	808.00
Day's Range	773.00 - 809.00
52-Week Range	636.00 - 860.00
Beta	0.45
RSI	43.02
Earnings Date	Mar 27, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.